Paradigm Biopharmaceuticals (ASX:PAR): An osteoarthritis solution that could hit the market within 3 years

If you thought the were plenty of treatments for osteoarthritis already, Paradigm Biopharmaceuticals (ASX:PAR) is a company that has something…

Cann Group (ASX:CAN): Successfully producing GMP medicinal cannabis since 2017

Cann Group (ASX:CAN) is the first company in Australia that was issued a medicinal cannabis license, granted by the Australian…

CET1 ratio: If you invest in ASX bank stocks, here’s why it is an important metric to know

In this article we look at the Common Equity Tier 1 (CET1) ratio – what it is and why it…

Star Entertainment Group (ASX:SGR): Where to now in a post-COVID world? Can it avoid a looming cash crunch?

In a July interview with the AFR, Star Entertainment Group boss Steve McCann admitted that his company’s pre-pandemic glory days…

Prescient Therapeutics (ASX:PTX): About to take the plunge into a Phase 2 trial against T-Cell Lymphoma

There’s plenty of ASX oncology biotechs conducting clinical trials, but Prescient Therapeutics (ASX:PTX) is one of the closest to commercialisation.…

5 crucial things to look for in the annual report of an ASX company that may give you an advantage over other investors

5 crucial things to look out for in the annual report of an ASX company! The ASX reporting season is…

Humm Group (ASX:HUM): Its no Big 4 Bank, but has defied the market in 2024

Humm Group (ASX:HUM) has not had the year you might expect to a financier that is not either a Big…

Here are 5 ASX stocks at 12 month highs, and whether it is time to buy

Here are 5 ASX stocks at 12 month highs! Humm Group (ASX:HUM) Humm has been through a difficult few…

Percheron Therapeutics (ASX:PER): Releasing Phase II data by the end of CY24, and successful data could lead to a major re-rate

It has been less then a year since Antisense Therapeutics changed its name to Percheron Therapeutics (ASX:PER). It is common…

Underlying v Statutory results? There’s a big difference between the 2 – here’s how to tell

When companies report results, you’ll hear underlying and statutory results. What is the difference between the two and how big…

Should I buy Woolworths or Coles shares in FY25?

Should I buy Woolworths or Coles shares? This is one of the top debates Australian investors can have. Obviously, this…

Qantas’ capex bill: The company is coping with a $12bn+ bullet for now, but will it eventually bite shareholders?

Qantas‘ capex needs are bubbling under the surface, but have not gone away. Former CEO Alan Joyce’s tenure came to…

Here are 5 key takeaways from the FY24 results of BHP that you may’ve missed

5 key takeaways from the FY24 results of BHP 1. Copper will be where ‘it is at’ from hereon…

Inghams (ASX:ING): Why the sudden volatility in the last 12 months?

It has been a volatile year on the ASX and poultry company Inghams (ASX:ING) has not been an exception. Between…

Should you buy Nvidia shares in Australia?

Many investors are likely wondering if they should buy Nvidia shares in Australia? Others still might be wondering just who…

Why do ASX REITs trade at a discount to NTA and is it a good or bad sign?

So, your ASX REIT is trading at a ‘discount to NTA’ (Net Tangible Assets). What does this mean – is…

Here’s why Kogan (ASX:KGN) should be on your watchlist for FY25

Kogan shares (ASX:KGN) have been volatile in the past couple of years, but is a better future ahead of it? At…

Proteomics International Laboratories (ASX:PIQ): It thinks its got a great DKD detection test, but do regulators agree?

Proteomics International Laboratories (ASX:PIQ) is the larger companies that will be presenting at next month’s Life Sciences Conference. Capped at…

What is depreciation? And why is it such an important thing for investors to watch?

Whenever companies report earnings before depreciation, interest, taxes and amortisation (EBITDA), many investors may be wondering what is depreciation? And…

Cyclopharm (ASX:CYC): Meet the latest ASX health stock making money from the USA!

Cyclopharm (ASX:CYC) is a rare species – an ASX stock that has just cracked the US market, but where the…

Dimerix (ASX:DXB): This exciting Phase 3 biotech could be about to follow in the footsteps of Telix and Neuren

Dimerix (ASX:DXB) is one of the few ASX biotechs in the middle of a Phase 3 trial, and it even…

Aussie Broadband (ASX:ABB): A likeable telco that can reach for the skies again

Aussie Broadband (ASX:ABB) is a good illustration of a Telco stock you can like (as opposed to Telstra). Since listing on…

6 ASX stocks you forgot were listed

Here are 6 ASX stocks you forgot were listed Brisbane Broncos (ASX:BBL) No it is not a mistake. This…

Infomedia (ASX:IFM) is set to rebound strongly in CY24 with the worst of the Tech Wreck behind us

Infomedia (ASX:IFM) is one tech stock that was unfairly sold off during the tech-wreck, but is gradually rebounding with a…

Atlassian (NDQ:TEAM): Why is this Aussie home grown tech company missing the Tech Rebound?

Are Aussie investors really poorer for not having Atlassian (NDQ:TEAM) on the ASX? While many of the ASX’s tech stocks…

Here are 5 Monkeypox stocks to consider as the fight against the epidemic continues

Monkeypox stocks have enjoyed a good run in the last few weeks, with the World Health Organisation (WHO) classifying Monkeypox…

Just when it appeared time to buy A2 Milk (ASX:A2M) again, investors have fresh concerns

A2 Milk shares have been listed on the ASX for over 9 years, listing in late March 2015 at $2.30…

Here are 6 important milestones of ASX biotech companies other than clinical trial results and regulatory approval

The list of major milestones of ASX biotech companies is headed with clinical trial results, regulatory approval and commercialisation. However,…

Recce Pharmaceuticals investors are excited despite the market volatility – and there’s good reason

Recce Pharmaceuticals investors are amongst the few investors in ASX stocks that have a reason to smile right now. Their…

An Investors’ Guide to Critical Minerals: What are they, why are they critical & how to invest in them?

Critical Minerals is the buzzword of the decade in the commodities sector. They’re not just any minerals, they are minerals…

Retail Food Group (ASX:RFG): The most underrated ASX fast food stock might be about to boost its profile

Retail Food Group (ASX:RFG) is flying under many investors’ radars, and we think it is simply because its share price…

Reliance Worldwide (ASX:RWC): Plumbing supplies as a 4-decade high inflation hedge

Reliance Worldwide (ASX:RWC) is one of the best companies to hold amidst record-high inflation, in our view. As a plumbing supplies…

Here are 5 ASX stocks with fluctuating fortunes that have been firmly manifest this reporting season

Here are 5 ASX stocks with fluctuating fortunes (as observed this reporting season) Baby Bunting (ASX:BBN) Baby Bunting has…

4 reasons why Pro Medicus (ASX:PME) just keeps rising to new heights

Another reporting season, another impressive result from Pro Medicus (ASX:PME). Eerily similar to the debate going on about CBA (ASX:CBA),…

Auswide and MyState are merging, will the Big 4 Banks be watching closely?

The biggest market news on August 19, 2024 was that Auswide and MyState are merging. The two small cap bank…

Merck & Co (NYSE:MRK): Its a top 5 healthcare company, but needs to figure out its post-Keytruda future

Merck & Co (NYSE:MRK) is one of the world’s most prominent healthcare companies. The healthcare industry is perceived by many…

Here are 4 economic indicators that impact stocks and investors must pay attention to

There are several economic indicators that impact stocks, both on the ASX and internationally. Whenever data is released, it can…

6 of the best performing ASX All Ords stocks in the past year

6 of the best performing ASX All Ords stocks in the past year Clarity Pharmaceuticals (ASX:CU6) Clarity is a…

Here are 5 Warren Buffett stock moves that were made in the last quarter

Last week was one of those 4 times per annum we get to see some Warren Buffett stock moves. Berkshire…

Resouro Strategic Metals (ASX:RAU): What other ASX rare earths developer has a 1.7 billion tonne deposit?

To say Resouro Strategic Metals (ASX:RAU) has got a monster of a rare earths deposit is an understatement. Resouro just…

Does Macquarie Group (ASX:MQG) deserve its reputation as the ‘millionaires factory’? And will it continue into FY25?

Macquarie Group (ASX:MQG) has a reputation as the ‘millionaire’s factory’, and it did not just develop it by accident. Despite…

Island Pharmaceuticals (ASX:ILA): One of the rare ASX biotechs fighting mosquito diseases – and its in Phase 2

Island Pharmaceuticals (ASX:ILA) is one of the few (if not the only) ASX-listed Biotechs that is focused on mosquito diseases,…

Does your company have an underperforming board? Here’s how to get rid of them: A s.249D notice!

Has your company got an underperforming board running your company and want to replace them? It’s possible and easy in…

Should I buy AGL Energy (ASX:AGL) as a hedge against inflation in FY25?

Should I buy AGL Energy (ASX:AGL)? That’s a question many investors would be forgiven for asking themselves when hearing that…

As lower interest rates loom, here are 6 ASX stocks that will benefit from forthcoming rate cuts

Here 6 ASX stocks that will benefit from lower interest rates! AGL Energy (ASX:AGL) You might think AGL is…

CSL (ASX:CSL): Expecting double-digit earnings growth for the rest of the 2020s

CSL is the ASX’s largest healthcare stock and the third biggest company behind BHP (ASX:BHP) and CBA (ASX:CBA). Capped at…

Curvebeam AI (ASX:CVB): Could this company be the next Pro Medicus?

Not many ASX medtech companies can boast of a then US President elect as a patient, but Curvebeam AI (ASX:CVB)…

Here are 5 of the worst stock market crashes of all time

If you thought the recent correction was bad, you thought wrong – it pales in comparison to the worst stock…

Mirvac (ASX:MGR): Things are set to get worse before they get better

Founded in 1972, Mirvac (ASX:MGR) is Australia’s largest listed developer of residential, commercial and industrial property. Arguably, it is one…

Actinogen Medical (ASX:ACW): Will history repeat itself? Can it bounce back from a troublesome Phase 2 trial?

If you thought you were having a bad Monday, spare a thought for Actinogen Medical (ASX:ACW) shareholders who saw their…

Eli Lilly (NYSE:LLY): Is this US$700bn company the biggest threat to Novo Nordisk & Ozempic?

For investors who missed out on Novo Nordisk, or reckon it is overvalued, Eli Lilly (NYSE:LLY) could be the next…

Here are 4 family owned ASX companies to watch eagerly

Family owned ASX companies are a rare breed. We’re not talking about companies that are still founder-led, we’re talking about…

If my company gets hit by a ASX Price Query, what does it mean and is it good or bad?

An ASX price query, or a speeding ticket, is commonly issued to ASX companies that record unexpected share price movements…

What is the VIX and what are the factors that cause it to violently surge and go into tailspins?

You may hear the occasional passing comment that the market is volatile, but the VIX Index (also known as the…

Is another boom in ASX BNPL stocks brewing? And how would Mk. 2 differ from Mk. 1

Is a new era on the horizon for ASX BNPL stocks? After a boom that lasted from Afterpay’s May 2016…

Liontown Resources (ASX:LTR): Have collapsed lithium prices sent the one-time market darling from spectacular riches to rags?

We’ve all heard the saying ‘rags to riches’ and when Liontown Resources (ASX:LTR) found Kathleen Valley, it was the perfect…

Credit Corp (ASX:CCP): Will FY25 be a better year?

Credit Corp (ASX:CCP) was one of the first stocks to release its FY24 results, having done so last week. Its…

Here’s how to use stop losses to help you minimise investment losses and protect your gains

A stop loss is one of the best ways for investors to minimise losses on any investment. It is a pre-determined…

Here’s why investors fear a US recession, and whether the fears are justified

Investors fear a US recession – there’s no denying it and there’s no other explanation for the market correction in…

Does Adore Beauty (ASX:ABY) have a better future ahead of it?

Let’s take a look at Adore Beauty (ASX:ABY). We know the IPO was horrible and the ghosts of it still…

Colgate (NYSE:CL): There’s more to it than toothpaste – it could be the best way to profit from the growth in pet products!

In Australia, we know Colgate (NYSE:CL) primarily as a toothpaste brand. But there’s a lot more to this 217-year old…

4 red flags in IPO’s to watch out for

If and when the 2023 IPO market opens up, here are 4 red flags in IPO’s to watch out for.…

Stock options: Here’s how investors can use them to their advantage

Do you hold Stock options? If so, you could be in a ‘no-lose’ situation as an investor. If your company…

Your stock needs a moat! Here’s why it is so important

What is a moat? A 20th century dictionary would tell you it is a river surrounding a castle that provided…

When will interest rate cuts happen? Could mortgage relief come this year or not until 2025?

When will interest rate cuts happen? Seemingly they will occur this year, although there is a disconnect between what investors…

6 ASX Stocks to watch with an eager eye this FY24 reporting season

6 ASX Stocks to watch this FY24 reporting season Nick Scali (ASX:NCK) Nick Scali has doubled in the last…

Relative Strength Index (RSI): Here’s how investors can use it to their advantage

One of the simplest technical indicators that investors can employ is the Relative Strength Index (RSI). How does it work…

Clarity Pharmaceuticals (ASX:CU6) has surged over 600% in the last year to be a $2bn company! Is it the next Telix?

Clarity Pharmaceuticals (ASX:CU6) is now a multi-billion dollar company, less than 3 years after an IPO that valued the company…

Airbnb shares have flatlined since the December 2020 IPO, but are they about to take off?

Airbnb shares have been fascinating to watch since listing in December 2020, because they have not performed as investors may…

These ASX biotechs are working with the US Department of Defence to bring new drugs to market and have a bright future ahead

Think of ASX stocks working with the US Department of Defence, and investors might imagine defence stocks or perhaps even…

Stock Market Basics

Start Investing in Australia

Where to Invest In

Nick Sundich

Get in touch

Follow us on